diferencias entre semaglutide y tirzepatide Diferencia GLP-1 semaglutida: guía médica completa Semaglutida vs Tirzepatida: qué fármaco

16:e70129

Key benefits for perimenopausal women: Targets visceral and subcutaneous fat accumulation that tends to increase as estrogen declines and metabolism slows Does not affect blood sugar or cause stimulant-related side effects such as anxiety or elevated heart rate Supports fat loss while preserving lean muscle tissue, important for maintaining metabolic rate during hormonal transition Administration method: Subcutaneous injection into abdominal fatty tissue, typically 2 inches from the navel

Statements Author contributions All authors made substantial contributions to the work and approved the final version of the manuscript

Neither medication works as a standalone solution

CA-L has received consulting fees from Sanofi and Novo Nordisk